Advances in cell and gene therapy are expanding the therapeutic frontier in oncology and immune modulation, but overcoming barriers such as limited persistence, antigen escape, and the immunosuppressive tumor microenvironment remains a key challenge. In this Biocompare webinar, two experts in the field—Yvonne Chen (University of California, Los Angeles) and Ellen Puré (University of Pennsylvania)—will discuss the next generation of mechanistic and translational strategies that are shaping how these therapies are designed and optimized.
Dr. Chen, known for her work on synthetic CAR T-cell architectures, will explore how rational design, combinatorial signaling, and control circuits can enhance safety and efficacy. Dr. Puré will share insights into stromal–immune crosstalk within the tumor microenvironment and how stromal modulation can potentiate durable therapeutic responses.
What you'll learn in this webinar:
Register today to gain valuable insights into how two leading labs are bridging molecular innovation with clinical translation to advance cell and gene therapies.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.